Welcome!

News Feed Item

Renal Pain Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Renal Pain Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703965/Renal-Pain-Global-Clinical-Trials-Review-H2-2014.html

Renal Pain Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Renal Pain Global Clinical Trials Review, H2, 2014" provides data on the Renal Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Renal Pain 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Pain to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Renal Pain 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Renal Pain Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
Emcure Pharmaceuticals Ltd. 31
Clinical Trial Overview of Emcure Pharmaceuticals Ltd. 31
Clinical Trial Overview of Top Institutes / Government 32
Tehran University of Medical Sciences 32
Clinical Trial Overview of Tehran University of Medical Sciences 32
Seoul National University Hospital 33
Clinical Trial Overview of Seoul National University Hospital 33
University of Minnesota 34
Clinical Trial Overview of University of Minnesota 34
The International Kidney Stone Institute 35
Clinical Trial Overview of The International Kidney Stone Institute 35
Yale University 36
Clinical Trial Overview of Yale University 36
Ahvaz Jundishapur University of Medical Sciences 37
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 37
Isfahan University of Medical Sciences 38
Clinical Trial Overview of Isfahan University of Medical Sciences 38
Department of Health, UK 39
Clinical Trial Overview of Department of Health, UK 39
University of Monastir 40
Clinical Trial Overview of University of Monastir 40
Korea Institute of Oriental Medicine 41
Clinical Trial Overview of Korea Institute of Oriental Medicine 41
Five Key Clinical Profiles 42
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 64

List of Tables

Renal Pain Therapeutics, Global, Clinical Trials by Region, 2014* 7
Renal Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Renal Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Renal Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Renal Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Renal Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Renal Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Renal Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Renal Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Renal Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Renal Pain Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Renal Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Renal Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Renal Pain Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Renal Pain Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Renal Pain Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Renal Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Renal Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Renal Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Renal Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Renal Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 30
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Emcure Pharmaceuticals Ltd., 2014* 31
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 32
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 33
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 34
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The International Kidney Stone Institute, 2014* 35
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 36
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014* 37
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2014* 38
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014* 39
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Monastir, 2014* 40
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea Institute of Oriental Medicine, 2014* 41

List of Figures

Renal Pain Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Renal Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Renal Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Renal Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Renal Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Renal Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Renal Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Renal Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Renal Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Renal Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Renal Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Renal Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Renal Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Renal Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Renal Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Renal Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Renal Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Renal Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 63


Read the full report:
Renal Pain Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703965/Renal-Pain-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
What happens when the different parts of a vehicle become smarter than the vehicle itself? As we move toward the era of smart everything, hundreds of entities in a vehicle that communicate with each other, the vehicle and external systems create a need for identity orchestration so that all entities work as a conglomerate. Much like an orchestra without a conductor, without the ability to secure, control, and connect the link between a vehicle’s head unit, devices, and systems and to manage the ...
"Once customers get a year into their IoT deployments, they start to realize that they may have been shortsighted in the ways they built out their deployment and the key thing I see a lot of people looking at is - how can I take equipment data, pull it back in an IoT solution and show it in a dashboard," stated Dave McCarthy, Director of Products at Bsquare Corporation, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
In his session at Cloud Expo, Robert Cohen, an economist and senior fellow at the Economic Strategy Institute, provideed economic scenarios that describe how the rapid adoption of software-defined everything including cloud services, SDDC and open networking will change GDP, industry growth, productivity and jobs. This session also included a drill down for several industries such as finance, social media, cloud service providers and pharmaceuticals.
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, discussed the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
Enterprise IT has been in the era of Hybrid Cloud for some time now. But it seems most conversations about Hybrid are focused on integrating AWS, Microsoft Azure, or Google ECM into existing on-premises systems. Where is all the Private Cloud? What do technology providers need to do to make their offerings more compelling? How should enterprise IT executives and buyers define their focus, needs, and roadmap, and communicate that clearly to the providers?
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of Soli...
SYS-CON Events announced today that Dataloop.IO, an innovator in cloud IT-monitoring whose products help organizations save time and money, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Dataloop.IO is an emerging software company on the cutting edge of major IT-infrastructure trends including cloud computing and microservices. The company, founded in the UK but now based in San Fran...
Join Impiger for their featured webinar: ‘Cloud Computing: A Roadmap to Modern Software Delivery’ on November 10, 2016, at 12:00 pm CST. Very few companies have not experienced some impact to their IT delivery due to the evolution of cloud computing. This webinar is not about deciding whether you should entertain moving some or all of your IT to the cloud, but rather, a detailed look under the hood to help IT professionals understand how cloud adoption has evolved and what trends will impact th...
In his session at 19th Cloud Expo, Claude Remillard, Principal Program Manager in Developer Division at Microsoft, contrasted how his team used config as code and immutable patterns for continuous delivery of microservices and apps to the cloud. He showed how the immutable patterns helps developers do away with most of the complexity of config as code-enabling scenarios such as rollback, zero downtime upgrades with far greater simplicity. He also demoed building immutable pipelines in the cloud ...
"We are the public cloud providers. We are currently providing 50% of the resources they need for doing e-commerce business in China and we are hosting about 60% of mobile gaming in China," explained Yi Zheng, CPO and VP of Engineering at CDS Global Cloud, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Businesses and business units of all sizes can benefit from cloud computing, but many don't want the cost, performance and security concerns of public cloud nor the complexity of building their own private clouds. Today, some cloud vendors are using artificial intelligence (AI) to simplify cloud deployment and management. In his session at 20th Cloud Expo, Ajay Gulati, Co-founder and CEO of ZeroStack, will discuss how AI can simplify cloud operations. He will cover the following topics: why clou...
"We are a custom software development, engineering firm. We specialize in cloud applications from helping customers that have on-premise applications migrating to the cloud, to helping customers design brand new apps in the cloud. And we specialize in mobile apps," explained Peter Di Stefano, Vice President of Marketing at Impiger Technologies, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
IoT solutions exploit operational data generated by Internet-connected smart “things” for the purpose of gaining operational insight and producing “better outcomes” (for example, create new business models, eliminate unscheduled maintenance, etc.). The explosive proliferation of IoT solutions will result in an exponential growth in the volume of IoT data, precipitating significant Information Governance issues: who owns the IoT data, what are the rights/duties of IoT solutions adopters towards t...
As data explodes in quantity, importance and from new sources, the need for managing and protecting data residing across physical, virtual, and cloud environments grow with it. Managing data includes protecting it, indexing and classifying it for true, long-term management, compliance and E-Discovery. Commvault can ensure this with a single pane of glass solution – whether in a private cloud, a Service Provider delivered public cloud or a hybrid cloud environment – across the heterogeneous enter...